MetaADEDB 2.0 @ LMMD
Lanthanum carbonate hydrate
(AFCUGQOTNCVYSW-UHFFFAOYSA-H)
Structure
SMILES
[O-]C(=O)[O-].[O-]C(=O)[O-].[O-]C(=O)[O-].O.[La+3].[La+3]
Molecular Formula:
C3H2La2O10
Molecular Weight:
475.853
Log P:
-7.4053
Hydrogen Bond Acceptor:
10
Hydrogen Bond Donor:
1
TPSA:
198.8
CAS Number(s):
N/A
Synonym(s)
1.
Lanthanum carbonate hydrate
External Link(s)
PubChem Compound176168
KEGGdr:D04667
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Abdominal PainOFFSIDES
2Acid refluxOFFSIDES
3Activated partial thromboplastin time shortenedOFFSIDES
4Acute myocardial infarctionOFFSIDES
5Adverse eventOFFSIDES
6AlveolitisOFFSIDES
7AmputationOFFSIDES
8AngioplastyOFFSIDES
9AnhedoniaOFFSIDES
10AnhidrosisOFFSIDES
11AnorexiaOFFSIDES
12Anoxic EncephalopathyOFFSIDES
13Anti-erythropoietin antibody positiveOFFSIDES
14ApathyOFFSIDES
15ArteriosclerosisOFFSIDES
16Arteriovenous fistula occlusionOFFSIDES
17Arteriovenous fistula thrombosisOFFSIDES
18Arteriovenous graft site infectionOFFSIDES
19Arteriovenous graft thrombosisOFFSIDES
20Aspiration PneumoniaOFFSIDES
21AsterixisOFFSIDES
22AstheniaOFFSIDES
23AtherosclerosisOFFSIDES
24Atrial thrombosisOFFSIDES
25Axillary vein thrombosisOFFSIDES
26BK virus infectionOFFSIDES
27Bacteria urine identifiedOFFSIDES
28Biliary cancer metastaticOFFSIDES
29Biopsy small intestine abnormalOFFSIDES
30Blood GlucoseOFFSIDES
31Blood count abnormalOFFSIDES
32Blood electrolytes abnormalOFFSIDES
33Blood glucose fluctuationOFFSIDES
34Blood lactate dehydrogenase decreasedOFFSIDES
35Blood pH decreasedOFFSIDES
36Blood pH increasedOFFSIDES
37Blood phosphorusOFFSIDES
38Blood pressure fluctuationOFFSIDES
39Blood thyroid stimulating hormone increasedOFFSIDES
40Blood urea increasedOFFSIDES
41BradycardiaOFFSIDES
42Brain ContusionOFFSIDES
43Burning sensationOFFSIDES
44Cardiac TamponadeOFFSIDES
45Cardiac infectionOFFSIDES
46Cardioactive drug level increasedOFFSIDES
47Carotid bruitOFFSIDES
48Catheter sepsisOFFSIDES
49Catheter site erythemaOFFSIDES
50Catheter site infectionOFFSIDES
51CellulitisOFFSIDES
52Central nervous system massOFFSIDES
53Cerebral atrophyOFFSIDES
54Cerebral ventricle dilatationOFFSIDES
55Cervical myelopathyOFFSIDES
56Cervicobrachial syndromeOFFSIDES
57Chest PainOFFSIDES
58Choking sensationOFFSIDES
59CholecystitisOFFSIDES
60Chronic Obstructive Airway DiseaseOFFSIDES
61Concomitant disease aggravatedOFFSIDES
62ConfabulationOFFSIDES
63ContractureOFFSIDES
64Cor pulmonaleOFFSIDES
65Culture wound positiveOFFSIDES
66DependenceCanada Vigilance: 1Canada Vigilance
67Depressed Level of ConsciousnessOFFSIDES
68Device malfunctionOFFSIDES
69Device related infectionOFFSIDES
70Diabetic RetinopathyOFFSIDES
71DiarrheaOFFSIDES
72Disease complicationOFFSIDES
73DizzinessOFFSIDES
74DrowsinessOFFSIDES
75Drug administration errorOFFSIDES
76DyslogiaOFFSIDES
77Economic problemOFFSIDES
78Electromechanical dissociationOFFSIDES
79Embolic strokeOFFSIDES
80EndocarditisOFFSIDES
81Enterococcal infectionOFFSIDES
82Enterococcal sepsisOFFSIDES
83Erosive gastritisOFFSIDES
84ErythemaOFFSIDES
85Failure to ThriveOFFSIDES
86Femoral arterial stenosisOFFSIDES
87Foreign body aspirationOFFSIDES
88GangreneOFFSIDES
89Gastric adenomaOFFSIDES
90Gastric ulcerOFFSIDES
91GastroenteritisOFFSIDES
92Gastrointestinal arteriovenous malformationOFFSIDES
93GlaucomaOFFSIDES
94Graft dysfunctionOFFSIDES
95HemiparesisOFFSIDES
96High turnover osteopathyOFFSIDES
97HyperpigmentationOFFSIDES
98HypophagiaOFFSIDES
99HyporeflexiaOFFSIDES
100Incorrect route of drug administrationOFFSIDES
101Infusion site mobility decreasedOFFSIDES
102Infusion site painOFFSIDES
103Intestinal ObstructionCanada Vigilance: 1Canada Vigilance
104Joint Range of Motion DecreasedOFFSIDES
105Joint stiffnessOFFSIDES
106LacerationOFFSIDES
107Left Ventricular HypertrophyOFFSIDES
108LethargyOFFSIDES
109LipaseOFFSIDES
110Livedo ReticularisOFFSIDES
111Low turnover osteopathyOFFSIDES
112LymphedemaOFFSIDES
113LymphocytosisOFFSIDES
114MalabsorptionOFFSIDES
115Mallory-Weiss SyndromeOFFSIDES
116Mastication disorderOFFSIDES
117Medical device complicationOFFSIDES
118Medication residueOFFSIDES
119MeningiomaOFFSIDES
120Mononucleosis syndromeOFFSIDES
121Muscle tightnessOFFSIDES
122NauseaOFFSIDES
123Nephrogenic Fibrosing DermopathyOFFSIDES
124Optic NeuropathyOFFSIDES
125OsteochondrosisOFFSIDES
126OverdoseCanada Vigilance: 1Canada Vigilance
127PCO2 decreasedOFFSIDES
128Pacemaker complicationOFFSIDES
129Pain of skinOFFSIDES
130PainOFFSIDES
131PallorOFFSIDES
132PancreatitisOFFSIDES
133Parvovirus B19 serology positiveOFFSIDES
134Performance status decreasedOFFSIDES
135Pericardial effusionOFFSIDES
136Peritoneal DialysisOFFSIDES
137Peritoneal cloudy effluentOFFSIDES
138PeritonitisOFFSIDES
139Phantom painOFFSIDES
140PityriasisOFFSIDES
141Pneumatic compression therapyOFFSIDES
142Portal hypertensive gastropathyOFFSIDES
143Post inflammatory pigmentation changeOFFSIDES
144Potentiating drug interactionOFFSIDES
145Precocious PubertyOFFSIDES
146Prescribed overdoseOFFSIDES
147Pulmonary congestionOFFSIDES
148Regurgitation of foodOFFSIDES
149Renal cystOFFSIDES
150Renal tubular necrosisOFFSIDES
151Respiratory FailureOFFSIDES
152Restrictive cardiomyopathyOFFSIDES
153Retinal vascular thrombosisOFFSIDES
154Risus sardonicusOFFSIDES
155SclerodactyliaOFFSIDES
156Septic ShockOFFSIDES
157SeromaOFFSIDES
158Shunt aneurysmOFFSIDES
159Shunt malfunctionOFFSIDES
160Shunt thrombosisOFFSIDES
161Sick Sinus SyndromeOFFSIDES
162SigmoiditisOFFSIDES
163Skin IndurationOFFSIDES
164Skin hypertrophyOFFSIDES
165Skin necrosisOFFSIDES
166Skin tightnessOFFSIDES
167SubileusOFFSIDES
168Sudden Cardiac DeathOFFSIDES
169Sudden deathOFFSIDES
170Supraventricular tachycardiaOFFSIDES
171Transaminases increasedOFFSIDES
172Traumatic fractureOFFSIDES
173Troponin increasedOFFSIDES
174Unevaluable eventOFFSIDES
175Unresponsive to stimuliOFFSIDES
176Upper respiratory tract inflammationOFFSIDES
177Urinary tract infection staphylococcalOFFSIDES
178Urine leukocyte esteraseOFFSIDES
179Vascular graft complicationOFFSIDES
180Ventricular FibrillationOFFSIDES
181Ventricular hypokinesiaOFFSIDES
182Visual brightnessOFFSIDES
183Vitamin B 12 DeficiencyOFFSIDES
184VomitingCanada Vigilance: 1Canada Vigilance
185Wrong technique in drug usage processOFFSIDES
186XerosisOFFSIDES
187bone marrow fibrosisOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.